Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms” - Publication - Bridge of Knowledge

Your account

login

Search

Authors’ Response to the Letter by Lamarca et al. Entitled “Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration” Regarding “Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms”

Abstract

Citations

  • 1

    CrossRef

  • 0

    Web of Science

  • 1

    Scopus

Authors (13)

  • Photo of Eleftherios Chatzellis

    Eleftherios Chatzellis

  • Photo of Kosmas Daskalakis

    Kosmas Daskalakis

  • Photo of Anna Angelousi

    Anna Angelousi

  • Photo of Marina Tsoli

    Marina Tsoli

  • Photo of Krystallenia I. Alexandraki

    Krystallenia I. Alexandraki

  • Photo of Ewa Wachula

    Ewa Wachula

  • Photo of Amichay Meirovitz

    Amichay Meirovitz

  • Photo of Ofra Maimon

    Ofra Maimon

  • Photo of Simona Grozinsky-Glasberg

    Simona Grozinsky-Glasberg

  • Photo of David Gross

    David Gross

  • Photo of Beata Kos-Kudła

    Beata Kos-Kudła

  • Photo of Anna Koumarianou

    Anna Koumarianou

  • Photo of Gregory Kaltsas

    Gregory Kaltsas

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
NEUROENDOCRINOLOGY no. 110, edition 1-2, pages 158 - 160,
ISSN: 0028-3835
ISSN:
0028-3835
Publication year:
2020
DOI:
Digital Object Identifier (open in new tab) 10.1159/000503999
Verified by:
No verification

seen 44 times

Meta Tags